Genitourinary syndrome of menopause and vaginal atrophy
A native AnnaHealth article for GSM and vulvovaginal atrophy, based on the source treatment plan and organized around diagnosis, comfort measures, and local treatment options.
Center differentiator
Personalized menopause care with symptom-based planning, hormone counseling, non-hormonal alternatives, and coordination with bone, cardiovascular, and primary care follow-up.
Signature capabilities
- • Perimenopause and menopause planning
- • HRT and non-hormonal options
- • Vaginal dryness, painful intercourse, and PCOS support
Why this belongs in the menopause center
The source treatment plan frames vulvovaginal atrophy as a diagnosis made through history, exam, vaginal pH, and microscopy, then organizes management around comfort measures, intercourse support, and escalating local estrogen options. That structure aligns naturally with the Hormonal Wellness & Menopause Center rather than the dermogynecology center as a primary home.
This should still remain cross-linked to vulvovaginal dryness and pain pages, because patients often experience GSM symptoms as irritation, burning, or painful intercourse before they think of menopause-related tissue change.
What the native article should preserve
The native AnnaHealth version should preserve the diagnostic framing, comfort basics, lubrication support, and local treatment ladder rather than reduce the topic to one brief statement about dryness. The source is especially practical about dosing tiers and about reassessing persistent pain when atrophy treatment alone does not resolve symptoms.
That makes this article useful both as a patient education page and as a source-backed node the AI can route to when users ask about dryness, irritation after menopause, or pain with intercourse in midlife and beyond.
Repository role
This article should become the first detailed subtopic in the menopause center beyond its overview page. Later, it can pair with additional AnnaHealth-native entries on HRT basics, perimenopause symptoms, libido, and non-hormonal alternatives.